About Sonendo, Inc. 
Sonendo, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 7 Schemes (4.78%)
Foreign Institutions
Held by 3 Foreign Institutions (0.24%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
8 Million
(Quarterly Results - Dec 2024)
Net Profit:
-6 Million
Pharmaceuticals & Biotechnology
USD 0 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
0.75
-614.16%
0.00






